Immunome, Inc. (IMNM)
21.84
-0.37
(-1.67%)
USD |
NASDAQ |
Mar 03, 10:42
Immunome Total Liabilities (Quarterly) : 35.46M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 114.23M |
| Scholar Rock Holding Corp. | 166.72M |
| Stoke Therapeutics, Inc. | 52.16M |
| Nurix Therapeutics, Inc. | 163.82M |
| Prelude Therapeutics, Inc. | 36.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 299.38M |
| Shareholders Equity (Quarterly) | 263.92M |
| Debt to Equity Ratio | 0.0152 |
| Current Ratio | 8.902 |
| Net Debt Paydown Yield | -0.02% |